Pharmabiz

Generate:Biomedicines to begin global phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI

Generate:Biomedicines to begin global phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI: Somerville, Massachusetts Tuesday, Decembe ...
Pharmabiz

NPPA fixes retail prices of 11 new drugs

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 11 new drugs, fixed in its recent ...
Pharmabiz

CCRAS–CARI accelerates research to tackle obesity and metabolic syndrome

CCRAS–CARI accelerates research to tackle obesity and metabolic syndrome: Nandita Vijayasimha Bengaluru Tuesday, December 2, 2025, 08:00 Hrs [IST] The Central Council for Resear ...
Pharmabiz

Commerce ministry seeks inputs on pharma trade related issues being faced with Japan

Commerce ministry seeks inputs on pharma trade related issues being faced with Japan: Shardul Nautiyal, Mumbai Tuesday, December 2, 2025, 08:00 Hrs [IST] The Department of Commerc ...
Pharmabiz

High-level Kenyan delegation to discuss investments, regulatory landscape with Indian pharma industry

High-level Kenyan delegation to discuss investments, regulatory landscape with Indian pharma industry: Shardul Nautiyal, Mumbai Tuesday, December 2, 2025, 08:00 Hrs [IST] High-lev ...
Pharmabiz

Telangana DCA launches ODLS website to facilitate public verification of medical shop licenses

Telangana DCA launches ODLS website to facilitate public verification of medical shop licenses: Peethaambaran Kunnathoor, Chennai Tuesday, December 2, 2025, 08:00 Hrs [IST] The Dr ...
Pharmabiz

CDSCO releases risk classification for 187 interventional radiology devices

CDSCO releases risk classification for 187 interventional radiology devices: Gireesh Babu, New Delhi Tuesday, December 2, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control ...
Pharmabiz

Elekta introduces Evo, its AI-powered, adaptive CT-Linac in India for cancer therapy

Elekta introduces Evo, its AI-powered, adaptive CT-Linac in India for cancer therapy: Our Bureau, Mumbai Monday, December 1, ...
Pharmabiz

Innovent's Pecondle, a recombinant anti-interleukin-23p19 subunit, receives China NMPA approval to treat moderate-to-severe plaque psoriasis

Innovent's Pecondle, a recombinant anti-interleukin-23p19 subunit, receives China NMPA approval to treat moderate-to-severe plaque psoriasis: San Francisco Monday, December 1, 202 ...
Pharmabiz

Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management

Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management: Beijing, China Monday, December 1, 2025, 18:00 Hrs [IST] Gan ...
Pharmabiz

SAI Parenteral's acquires Australia's Noumed Pharmaceuticals for Rs. 125 crore

SAI Parenteral's acquires Australia's Noumed Pharmaceuticals for Rs. 125 crore: Our Bureau, Mumbai Monday, December 1, 2025, 17:10 Hrs [IST] SAI Parenteral's Limited (SPL), a dive ...
Pharmabiz

HOSMAC leads design, engineering & construction, as Cipla unveils its modern Lung Health Centre in Delhi

HOSMAC leads design, engineering & construction, as Cipla unveils its modern Lung Health Centre in Delhi: Our Bureau, Bengaluru Monday, December 1, 2025, 16:50 Hrs [IST] HOSMAC, A ...